A great idea. A breakthrough on a big project. A bit of sound advice. The moment you realized it was time for a pivot, either personally or professionally. Some of our best learning comes in the form of the conversations we have with our colleagues, peers, loved ones, or even strangers. That’s the premise of Conversations WeLearn From — a new podcast brought to you by WeLearn. Learn more at welearnls.com.
Marketing can be more than merely capitalizing on fear, uncertainty, and doubt, the holy trinity of the marketing profession. It can be more than manipulation, hyperbole, and cringeworthy self-promotion. It can be more than a dashboard of leads and clicks. We believe that faith is ultimately more powerful than fear. Yes, you can be bold and even provocative. We encourage that. Yet we believe, these days, that it’s provocative to choose hope instead of giving into doom-scrolling and fear-mongering. We call this Redemptive Marketing.
Learn more at Snapmarket.co/philosophy
Josh and his family are planting Breakthrough Church in Richardson, TX. Their prayer is that Jesus would use them to advance His Kingdom and to see many receive healing and deliverance in His name. Josh is married to Abby and has three kids, two boys and one girl.
In this episode of "In the Interim...", Dr. Scott Berry dissects prevailing concepts of “clinically meaningful difference” in clinical trials focusing on progressive diseases. Through detailed examples from pancreatic cancer (Ben Sasse, Revolution Medicines), emphysema (Elevair), Alzheimer’s disease (lecanemab), and IVF, Scott challenges the adequacy of the population-mean of a continuous outcome in reflecting true patient benefit. The episode discusses inconsistent usage and interpretation of acronyms such as MCID, CSD, and Target Product Profile (TPP). Dr. Berry advises trialists to resist interpreting the mean difference using patient-level minimal effects, and adopt responder analyses and cumulative probability approaches to enhance patient-level relevance. Guidance is offered for analyzing the effect of time-saved instead of a mean differences in a clinical endpoint at a single time for progressive diseases – measuring “sweet time.”
Key Highlights
Focus on added time not the change from baseline as the most meaningful outcome for a progressive disease.
In-depth evaluation of MCID, CSD, TPP, and risk of misinterpretation.
Critique of trying to interpret mean-based endpoints for clinical meaningfulness such as six-minute walk distance and CDR sum of boxes.
FDA advisory panel guidance on MCID for IVF live birth endpoints and dichotomous versus continuous endpoints.
Advocacy for responder analyses and cumulative probability of achieving thresholds in reporting the clinical effect of a treatment.
For more, visit us at https://www.berryconsultants.com/
Everyone talks about the number on a signing bonus. Almost nobody talks about what happens to it before it reaches your account. In this episode, the guys break down when rookies and veterans actually get paid, why the state you play in and the team you sign with change how much you keep, and the specific tax-withholding strategy AWM's team used to put an extra $100,000 back in one client's pocket — all without any of it becoming a guessing game.
Chapters
[00:00] Welcome back to the NFL Players' Podcast
[00:00] Setting up today's topic: what's really happening behind the scenes with your signing bonus
[00:01] Why most rookies sign and walk away without asking the right questions
[00:02] When rookies actually get paid — the 15-day portion and the delayed remainder
[00:03] Veterans vs. rookies: how payment timing and negotiation differ
[00:03] The jock tax explained: how state and team both affect what you keep
[00:04] Newsflash: your full signing bonus doesn't hit your account
[00:05] Behind AWM's numbers: $45M+ in gross client signing bonuses this off-season
[00:06] Jeff's world: what AWM's tax team does the moment a client signs
[00:07] Two ways teams handle withholding — and the $100K strategy that worked
[00:08] Why team payroll departments say no one else does this
[00:09] The long-term payoff: paying more now to pay less later, the right way
Connect with us
• Call or text: 602-989-5022
• Website: https://www.athletefamilyoffice.com/
• LinkedIn: https://www.linkedin.com/company/awmcapital/
• Instagram: https://www.instagram.com/awmcapital/
• Facebook: https://www.facebook.com/awmcapital/
• X: https://twitter.com/awmcapital
Roger Ferguson Jr. has held two of the most consequential seats in American finance: Vice Chairman of the Federal Reserve and, later, CEO of TIAA, where he nearly tripled assets under management while steering the company through the Global Financial Crisis, COVID, and more.
In Part 1 of our three-part conversation, Roger traces the dining-room-table discipline that shaped him, his philosophy on raising kids who earn their own confidence, and the preparation habits that turned "Roger who?" into the Fed's second-most-powerful voice in under two years, all the way through to the values-driven investing chapter he's building now.
Connect with Us
Call or text us: 626-862-0355
Website: https://www.athletefamilyoffice.com/
YouTube: https://www.youtube.com/channel/UCc1NxpK21N1vKWEExC45YEA
LinkedIn: https://www.linkedin.com/company/awmcapital/
Instagram: https://www.instagram.com/awmcapital/
X: https://twitter.com/awmcapital
Facebook: https://www.facebook.com/awmcapital/
Chapters
[00:00] Introduction
[00:02] The Dining Room Table
[00:08] Money As A Tool, Not A Scorecard
[00:16] Sweeping The Shed At Harvard
[00:22] Raising Kids Who Earn Their Confidence
[00:29] Meeting His Wife and Co-CEO
[00:34] From "Roger Who?" To Vice Chairman of the Fed
[00:47] Compete, Don't Compare
[00:52] Taking Over TIAA In The Eye Of The GFC
[01:04] Knowing When To Leave
[01:09] What's Next
[01:12] Do Well And Do Good
#RogerFergusonJr #FederalReserve #TIAA #1hundredyearfamily #generationalwealth #financialliteracy #crisisleadership #deferredgratification #GlobalFinancialCrisis #mentalperformance #AWMCapital #AthleteFamilyOffice
In this episode of Travel Buddy by Switchfly, Ian Andersen is joined by Lucy Mui, Switchfly’s Market Manager and self-proclaimed solo travel enthusiast. Together, they explore the rise of solo adventures, the allure of “main character” trips, and how technology is making independent travel easier and more rewarding than ever. Lucy shares her personal journeys to destinations around the world, and offers practical insights into flexibility, personalization, and the power of authentic connections on the road. Tune in for a lively discussion brimming with tips, stories, and ideas to inspire your next memorable solo getaway.
Chapters
(00:00) Introductions and Solo Travel Experiences
(03:00) Defining Solo Travel and Personal Motivation
(08:00) Technology’s Impact on Travel Confidence
(09:00) Embracing Soft Adventure Travel
(11:00) The Main Character Trip and Personal Fulfillment
(19:00) Connection, Social Media, and Serendipity
(28:00) Implications for Travel and Loyalty Program Leaders
Connect with Switchfly
Website: https://www.switchfly.com/
LinkedIn: https://www.linkedin.com/company/switchfly/
X: https://twitter.com/switchfly
YouTube: https://www.youtube.com/@SwitchflyOfficial